Cargando…

Perspective and Experience of Patients with Aplastic Anemia on Medication Adherence

BACKGROUND: Drug treatment is critical for patients with aplastic anemia, and medication adherence directly impacts the therapeutic effect. Poor medication adherence is common among patients with chronic diseases. However, knowledge of the perceptions and experiences of patients with aplastic anemia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hangting, Wu, Xiaolian, Shen, Jiaoni, Lou, Shuhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493145/ https://www.ncbi.nlm.nih.gov/pubmed/37701429 http://dx.doi.org/10.2147/PPA.S390409

Ejemplares similares

Eltrombopag for the treatment of aplastic anemia: current perspectives
por: Lum, Su Han, et al.
Publicado: (2016)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

Osteonecrosis of the hip in patients with aplastic anemia.
por: Park, Jeongmi, et al.
Publicado: (2002)

Value of transfusion independence in severe aplastic anemia from patients’ perspectives – a discrete choice experiment
por: Pickard, A. Simon, et al.
Publicado: (2018)

Total Hip Arthroplasty in Patient with Aplastic Anemia
por: Lim, Young Wook, et al.
Publicado: (2016)

Evaluation of eltrombopag in patients with aplastic anemia in real-world experience
por: Konishi, Akiko, et al.
Publicado: (2019)

Idiopathic Aplastic Anemia: An Update
por: Solomou, Elena E.
Publicado: (2019)

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia
por: Contejean, Adrien, et al.
Publicado: (2019)

Cyclosporine monotherapy for severe aplastic anemia: a developing country experience
por: Al-Ghazaly, Jameel, et al.
Publicado: (2005)

THPO gene variants in patients with acquired aplastic anemia
por: Padilha, Pedro Henrique, et al.
Publicado: (2018)

Molecular alterations in the TCR signaling pathway in patients with aplastic anemia
por: Li, Bo, et al.
Publicado: (2016)

Dioscin Regulating Bone Marrow Apoptosis in Aplastic Anemia
por: Zhang, Le, et al.
Publicado: (2022)

Ecthyma gangrenosum associated with aplastic anemia.
por: Chun, W. H., et al.
Publicado: (1996)

Immunosuppressive therapy for pediatric aplastic anemia: a North American Pediatric Aplastic Anemia Consortium study
por: Rogers, Zora R., et al.
Publicado: (2019)

Angioinvasive mucormycosis in a patient with aplastic anemia
por: Moshayedi, Aref, et al.
Publicado: (2022)

Infections in patients with aplastic Anemia in Chiang Mai University
por: Lertpongpiroon, Rapee, et al.
Publicado: (2018)

Hematopoietic stem cell transplantation for severe aplastic anemia—experience of an institute in Taiwan
por: Bai, L. Y., et al.
Publicado: (2003)

Aplastic Anemia in Triple X Syndrome
por: Aldarwish, Mohammed, et al.
Publicado: (2023)

Aplastic anemia: immunosuppressive therapy in 2010
por: Risitano, Antonio M., et al.
Publicado: (2011)

Cephalosporin-induced recurrent aplastic anemia
por: Han, Jimin, et al.
Publicado: (2010)

Aplastic anemia, membranous nephropathy and mercury
por: Rooney, J.
Publicado: (2013)

Child with aplastic anemia: Anesthetic management
por: Kaur, Manpreet, et al.
Publicado: (2012)

Recent advances in treatment of aplastic anemia
por: Shin, Seung Hwan, et al.
Publicado: (2014)

Aplastic anemia in adult and pediatric hematology
por: Niemeyer, Charlotte
Publicado: (2019)

Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia
por: Lengline, Etienne, et al.
Publicado: (2018)

Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
por: Chen, Hai-Fei, et al.
Publicado: (2014)

Aplastic anemia in a petrochemical factory worker.
por: Baak, Y M, et al.
Publicado: (1999)

Immunosuppressive Treatment in Children with Acquired Aplastic Anemia
por: Yıldırmak, Yıldız, et al.
Publicado: (2012)

Gut inflammation in the pathogenesis of acquired aplastic anemia
por: Zhao, Xi-Chen, et al.
Publicado: (2020)

Medication Regularity of Traditional Chinese Medicine in the Treatment of Aplastic Anemia Based on Data Mining
por: Dong, Nanxi, et al.
Publicado: (2022)

Assessment of Hepatic Profile in Acquired Aplastic Anemia: An Experience From Pakistan
por: Thakur, Warkha, et al.
Publicado: (2022)

APC/C is essential for hematopoiesis and impaired in aplastic anemia
por: Wang, Jia, et al.
Publicado: (2017)

Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study
por: Liu, Qi, et al.
Publicado: (2022)

Bilateral Spontaneous Hyphemas in a Patient with Aplastic Anemia
por: Siddiqui, Mohammad Z., et al.
Publicado: (2018)

Aplastic Anemia in a Patient with Cronkhite-Canada Syndrome
por: Kidoguchi, Keisuke, et al.
Publicado: (2021)

Immunosuppressive therapy for aplastic anemia: a single-center experience from western India
por: Shah, Sandip, et al.
Publicado: (2018)

The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China
por: Wang, Huaquan, et al.
Publicado: (2014)

Identification of novel regulators in T-cell differentiation of aplastic anemia patients
por: Franzke, Anke, et al.
Publicado: (2006)

The Progress of Traditional Chinese Medicine in the Treatment of Aplastic Anemia
por: Zhu, Ningning, et al.
Publicado: (2018)

Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm
por: Füreder, Wolfgang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_va1nh4kptgqhqorah63575pfli